August 23, 2010. When we first complained about these ads in January, Seroquel was approved for schizophrenia and for psychosis associated with bipolar disorder.
Read More »On Medical Treatments & Products
Patient, Consumer, and Public Health Coalition Comments to the FDA on “Food Additives; Bisphenol A”
June 4, 2010. There are many unanswered questions about the risks of BPA on human health, especially prenatal exposures, infants, and children.
Read More »Testimony on Acurox
April 22, 2010. Although Acura Pharmaceuticals should be applauded for trying to reduce the misuse and abuse of oxycondone, the key question is: can Acurox easily be abused?
Read More »NCHR Testimony on Seroquel, Zyprexa and Geodon
June 9, 2009. NCHR was disappointed by the quality of the research presented for these three drugs, and the FDA’s failure to clearly present those shortcomings in this meeting.
Read More »Statement of NCHR At the April 8, 2009 FDA Psychopharmacologic Drugs Advisory Committee Meeting Regarding Seroquel XR
April 8, 2009. We testified arguing that Seroquel, an Antipsychotic medication, should be kept off the market as it has not been conclusively proven that it does not increase the risk of diabetes or tardive dyskinesia.
Read More »